Utkhede; Deepank

Patent Applications and Registrations

Patent applications and USPTO patent grants for Utkhede; Deepank.The latest application filed is for "ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment".

Company Profile

6.8.20

Utkhede; Deepank - Burnaby CA
Utkhede; Deepank - Surrey CA
Utkhede; Deepank - British Columbia CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Static pin insertion tool for lacrimal implant Grant 11,406,532 - Utkhede , et al. August 9, 2	2022-08-09
Ophthalmic drug sustained release formulation and uses thereof Grant 11,324,693 - Utkhede , et al. May 10, 2	2022-05-10
Ophthalmic Drug Sustained Release Formulation And Uses For Dry Eye Syndrome Treatment App 20210023165 - Utkhede; Deepank ; et al.	2021-01-28
Sustained Release Delivery Of Active Agents To Treat Glaucoma And Ocular Hypertension App 20200323685 - Cadden; Suzanne ; et al.	2020-10-15
Ophthalmic Drug Sustained Release Formulation And Uses Thereof App 20200222317 - UTKHEDE; Deepank ; et al.	2020-07-16
Sustained release delivery of active agents to treat glaucoma and ocular hypertension Grant 10,632,012 - Cadden , et al.	2020-04-28
Ophthalmic drug sustained release formulation and uses thereof Grant 10,603,274 - Utkhede , et al.	2020-03-31
Static Pin Insertion Tool For Lacrimal Implant App 20190247230 - Utkhede; Deepank ; et al.	2019-08-15
Drug Delivery System and Methods of Treating Open Angle Glaucoma and Ocular Hypertension App 20190091066 - Cadden; Suzanne ; et al.	2019-03-28
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension Grant 9,974,685 - Cadden , et al. May 22, 2	2018-05-22
Ophthalmic Drug Sustained Release Formulation And Uses Thereof App 20180092836 - UTKHEDE; Deepank ; et al.	2018-04-05
Sustained Release Delivery Of Active Agents To Treat Glaucoma And Ocular Hypertension App 20170202853 - Cadden; Suzanne ; et al.	2017-07-20
Sustained release delivery of active agents to treat glaucoma and ocular hypertension Grant 9,610,271 - Cadden , et al. April 4, 2	2017-04-04
Sustained Release Delivery Of One Or More Agents App 20150133546 - Butuner; Zuhal ; et al.	2015-05-14
Sustained Release Delivery Of One Or More Agents App 20150064230 - Butuner; Zuhal ; et al.	2015-03-05
Sustained Release Delivery Of Active Agents To Treat Glaucoma And Ocular Hypertension App 20140350103 - Cadden; Suzanne ; et al.	2014-11-27
Drug Cores For Sustained Release Of Therapeutic Agents App 20140186420 - Utkhede; Deepank ; et al.	2014-07-03
Drug Delivery System And Methods Of Treating Open Angle Glaucoma And Ocular Hypertension App 20140025022 - Cadden; Suzanne ; et al.	2014-01-23
Drug cores for sustained release of therapeutic agents Grant 8,628,792 - Utkhede , et al. January 14, 2	2014-01-14
Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof App 20130289089 - Morris; Jerome A. ; et al.	2013-10-31
Sustained Release Delivery Of Active Agents To Treat Glaucoma And Ocular Hypertension App 20130053794 - Cadden; Suzanne ; et al.	2013-02-28
Drug Cores For Sustained Release Of Therapeutic Agents App 20120187594 - Utkhede; Deepank ; et al.	2012-07-26
Sustained Release Delivery Of One Or More Agents App 20100209477 - BUTUNER; ZUHAL ; et al.	2010-08-19
Substance Delivering Punctum Implants And Methods App 20100189766 - Utkhede; Deepank ; et al.	2010-07-29
Drug cores for sustained release of therapeutic agents App 20090104243 - Utkhede; Deepank ; et al.	2009-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.